Scenes from Israel. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Recce Pharmaceuticals (ASX:RCE) has successfully obtained its first patent for its flagship anti-infective drug R327 in Israel.

The State of Israel Patent Office ticked off on patent #295116 under ‘Patent Family 4.’ The patent expires in 2041.

Recce’s flagship R327 drug has been approved for patent along with Recce 529 (R529).

The israeli patent effectively permits Recce to claim legal rights to the drug, its manufacture, and its distribution in the jurisdiction.

Both drugs will focus on bacterial infections and viral infections which the company hopes will produce further data validating the use of its drugs in a variety of conditions.

Those conditions include burn wounds, UTIs, the STI gonorrhoea, the flu, and even COVID. As for bacteria, E.coli and staph are among target conditions for Recce.

“Israel’s pharmaceuticals and biotech market has a reputation for high R&D spending,” the company said on Wednesday, highlighting the country’s healthcare spend in 2020 of 8.3% of GDP.

The company also highlighted figures from the Israeli stats office that the elderly population will grow by 77% to reflect 14.3% of the population at the start of 2040.

Recce shares were up 2.27% to 45cps at 10.30am AEDT.

RCE by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Market closes the week on a high | 12 July 2024

The ASX200 closed up 0.9% to 7959 points. All sectors finished the day in the green…
ASX chart prices

Week 27 Wrap: ASX hits all time high; CBA shares’ two realities; US inflation hits 3% ahead of China plenum

The ASX200 ended the week at a fresh all time high. Can we hit 8,000pts by…
The Market Online Video

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Infini Resources (ASX:I88) has unveiled what it believes could be the highest ever soil sample uranium concentrations found in Newfoundland, Canada, at its
The Market Online Video

ASX Market Update: ASX hits new record on lower than expected US inflation | 12 July 2024

The ASX200 has claimed a new record, reaching above 7,950 points on the back of positive futures.